HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CHZ868

a type II JAK2 kinase inhibitor with antineoplastic activity; structure in first source
Networked: 5 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Andraos, Rita: 2 articles (07/2015 - 07/2015)
2. Baffert, Fabienne: 2 articles (07/2015 - 07/2015)
3. Dölemeyer, Arno: 2 articles (07/2015 - 07/2015)
4. Ebel, Nicolas: 2 articles (07/2015 - 07/2015)
5. Gaul, Christoph: 2 articles (07/2015 - 07/2015)
6. Hofmann, Francesco: 2 articles (07/2015 - 07/2015)
7. Mandon, Emeline: 2 articles (07/2015 - 07/2015)
8. Murakami, Masato: 2 articles (07/2015 - 07/2015)
9. Radimerski, Thomas: 2 articles (07/2015 - 07/2015)
10. Romanet, Vincent: 2 articles (07/2015 - 07/2015)

Related Diseases

1. Inflammation (Inflammations)
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
3. Neoplasms (Cancer)
4. Leukemia

Related Drugs and Biologics

1. Janus Kinase Inhibitors
2. troxerutin
3. Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
4. Phosphotransferases (Kinase)